Floatz logo

Bedamustine

Child

Children's Cancer Group, ChinaPhase 2/3Active
B
57/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
42/ 100
Competitive Position
89/ 100

Competitive context

8 Active assets in the Child cohort.

Asset / SponsorPhaseRating
Thiamine
Mahidol University
Phase 4BB
Emicizumab
Kathelijn Fischer
Phase 4B
Inno-206
Children's Cancer Group, China
Phase 2/3B
PREDNISONE TABLETS
Children's Cancer Group, China
Phase 2/3B
DACARBAZINE
Children's Cancer Group, China
Phase 2/3B

View all 12 →

Same molecule, other indications

Bedamustine is also rated in:

Young AdultDormant
B
Indicative ·
57 / 100
View asset →
Metabolic ResponseDormant
B
Indicative ·
57 / 100
View asset →
PET ScanDormant
B
Indicative ·
57 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →